Hybridoma clones, monoclonal antibodies, and methods of use
US9738717B2 · kind B2 · utility
6Cited by
0References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 15, 2013 |
| Grant date | Aug 22, 2017 |
| Priority date | — |
| Expiry date | May 15, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is directed to a monoclonal antibody that recognizes human CD63 in its native form. The invention is also directed to a hybridoma cell line that produces the monoclonal antibody, and to methods of diagnosing and treating cancer and purifying exosomes using the antibody. The invention is further directed to pharmaceutical compositions comprising an antibody of the invention and a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.